Pacira Biosciences Inc
NASDAQ:PCRX
Revenue Breakdown
Breakdown by Geography
Pacira Biosciences Inc
Breakdown by Segments
Pacira Biosciences Inc
Total Revenue:
675m
USD
|
Net Product Sales:
672.2m
USD
|
Exparel:
538.1m
USD
|
Zilretta:
111.1m
USD
|
Iovera°:
19.7m
USD
|
Bupivacaine Liposome Injectable Suspension:
3.3m
USD
|
Royalty Revenue:
2.7m
USD
|